Samsung Biologics the world's leading contract development and manufacturing organization, held an award ceremony with the British Standard Institution at its Songdo headquarters for...
UCB announced that it has entered into a global co-development and co-commercialization agreement with Novartis covering UCB0599, a potential first in class, small molecule,...
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK,...
Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva® CTD Essential Reagent for use...
